Final ID: 54
Risk Factors and Prevention Oral Abstracts II
Wednesday, 02/05/2025 , 02:00PM - 03:00PM
Oral Abstract Session
Dhingra Lovedeep, Aminorroaya Arya, Pedroso Aline, Rajpura Jigar, Mehanna Sherif, Tonnu-mihara Ivy, Khera Rohan
A First-in-Class Humanized Antibody Fragment Targeting Platelet Glycoprotein Ibα: A Comprehensive Preclinical Study of CA1001 for the Treatment of Acute Ischemic StrokeXu Xiaohong, Preeti Preeti, Yu Ruoying, Shaykhalishahi Hamed, Zhang Cheng, Shen Chuanbin, Li Bei, Tang Naping, Chang Yan, Xiang Qian, Cui Yimin, Lei Xi, Ni Heyu, Zhu Guangheng, Liu Zhenze, Hu Xudong, Slavkovic Sladjana, Neves Miguel, Ma Wenjing, Xie Huifang
Stamm Brian, Woo Daniel, Wechsler Paul, Menzies Lauren, Wright Shea, Nobel Lisa, Slavin Sabreena, Walsh Kyle, Delosrioslarosa Felipe, Mackey Jason, Mistry Eva, Royan Regina, Demel Stacie, Coleman Elisheva, Jasne Adam, Star Michael, Martini Sharyl, Adeoye Opeolu, Flaherty Matthew, Khatri Pooja, Madsen Tracy, Broderick Joseph, Ding Lili, Kissela Brett, Kleindorfer Dawn, Robinson David, Haverbusch Mary, Ferioli Simona, Stanton Robert, Aziz Yasmin, Laporta Joseph
Trends in Stroke Symptom Onset to Emergency Department Arrival Time in the Greater Cincinnati and Northern Kentucky Stroke StudyRoyan Regina, Woo Daniel, Wechsler Paul, Menzies Lauren, Wright Shea, Nobel Lisa, Slavin Sabreena, Walsh Kyle, Delosrioslarosa Felipe, Mackey Jason, Mistry Eva, Stamm Brian, Demel Stacie, Coleman Elisheva, Jasne Adam, Star Michael, Martini Sharyl, Adeoye Opeolu, Madsen Tracy, Kissela Brett, Kleindorfer Dawn, Sucharew Heidi, Robinson David, Haverbusch Mary, Ferioli Simona, Stanton Robert, Aziz Yasmin, Laporta Joseph
We encourage you to enter the discussion by posting your comments and questions below.
Presenters will be notified of your post so that they can respond as appropriate.
This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.
You have to be authorized to post a comment. Please, Login or Signup.